SPRI | Dermal Drug Selection And Development: An Industrial Perspective (2017 EN)

Discussion in 'Medicine' started by Kanka, Nov 26, 2017.

  1. Kanka

    Kanka Well-Known Member Loyal User

    Messages:
    16,047
    Likes Received:
    449
    Trophy Points:
    83
    [​IMG]

    Author: Lionel Trottet, Howard Maibach
    Full Title: Dermal Drug Selection And Development: An Industrial Perspective
    Publisher: Springer; 1st ed. 2017 edition (August 8, 2017)
    Year: 2017
    ISBN-13: 9783319595047 (978-3-319-59504-7), 9783319595030 (978-3-319-59503-0)
    ISBN-10: 3319595040, 3319595032
    Pages: 148
    Language: English
    Genre: Biomedical Sciences: Pharmacology
    File type: EPUB (True), PDF (True)
    Quality: 10/10
    Price: 165.84 €


    The authors show how the pharmaceutical industry faces the development of dermal drugs and provide the only book of its kind that describes how the industry develops and selects dermal drugs, complete with the challenges and opportunities of the field. Delivery of drugs through the skin has been an attractive and challenging area for research, and advances in modern technologies have resulted in a larger number of drugs being delivered transdermally, including conventional hydrophobic small molecule drugs, hydrophilic drugs and macromolecules. Offering the perspective from the industrial side of selection and development of drugs, the primary audience is geared towards the pharmaceutical industry but can also offer valuable information to clinicians, compounding pharmacists, and similarly pharmacy students. Dermal Drug Selection and Development covers the

    scientific gaps that exist in terms of dermal pharmacokinetics and the resulting uncertainty by clinicians when choosing a drug candidate.

    -------------
     
    Last edited by a moderator: Dec 9, 2019